Moyamoya disease: case report and literature review

Paul H Janda1, Jonathan G Bellew, Venkatachalam Veerappan

  • 1Neurology residency training program, Valley Hospital Medical Center, Las Vegas, NV 89106-4119, USA. pauljanda@hotmail.com

Insights

Moyamoya disease, a progressive artery condition, causes strokes and is underrecognized in Western countries. This case highlights its occurrence in an African American woman, emphasizing the need for broader awareness.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Neuroscience

Background:

  • Moyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis of the terminal portion of the internal carotid arteries and the proximal portions of the anterior and middle cerebral arteries.
  • It leads to the formation of abnormal, fragile collateral vessels at the base of the brain, often described as a 'puff of smoke' on angiography.
  • While predominantly reported in East Asian populations, moyamoya disease affects individuals globally, presenting with diverse clinical features and age distributions.

Observation:

  • This report details a case of moyamoya disease in a 44-year-old African American woman.
  • The patient had a history of hypertension, cervical cancer, breast cancer, and a prior stroke, underscoring the varied comorbidities associated with the condition.
  • Diagnosis was confirmed through characteristic imaging findings, likely cerebral angiography.

Findings:

  • The case illustrates that moyamoya disease can occur in non-East Asian populations and in adults with significant medical histories.
  • The clinical presentation and diagnostic pathway in this patient align with known, albeit less common, manifestations of moyamoya disease.
  • Literature review provides a comprehensive overview of the disease's epidemiology, pathophysiology, clinical presentation, and diagnostic challenges.

Implications:

  • Increased recognition of moyamoya disease is crucial in Western countries, where it may be underdiagnosed as a cause of stroke.
  • This case emphasizes the importance of considering moyamoya disease in the differential diagnosis of ischemic and hemorrhagic strokes, irrespective of patient ethnicity or age.
  • Further research into the genetic and environmental factors contributing to moyamoya disease may improve diagnostic accuracy and therapeutic strategies.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...